| Financial Year |
March 31 2023 |
| Monetary Funds |
336,330,656.97 |
| Held-for-trading Financial Assets |
201,354,478.45 |
| Notes Receivable |
5,791,917.92 |
| Accounts Receivable |
290,601,482.51 |
| Advances to Suppliers |
5,671,561.04 |
| Other Receivables |
1,757,133.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
228,617,745.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,000,000.00 |
| Other Current Assets |
31,929,517.95 |
| Total Current Assets |
1,152,054,494.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
207,641,154.98 |
| Under-construction Projects |
5,483,075.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,132,571.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
237,263.57 |
| Deferred Income Tax Assets |
17,684,041.45 |
| Other Non-Current Assets |
145,111,444.24 |
| Sub-Total of Non-Current Assets |
426,955,717.66 |
| Total Assets |
1,579,010,212.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,036,109.30 |
| Accounts Payable |
110,215,509.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,406,456.36 |
| Taxes Payable |
7,643,519.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,526,565.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
563,272.67 |
| Other Current Liabilities |
1,818,438.52 |
| Sub-Total of Current Liabilities |
209,550,887.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,666,991.17 |
| Total Liabilities |
229,217,879.10 |
| Paid-In Capital(Or Share Stock) |
229,996,800.00 |
| Capital Surplus |
529,581,568.23 |
| Surplus Reserve |
114,998,400.00 |
| LESS:Treasury Stock |
99,871,365.90 |
| Undistributed Profits |
563,814,530.23 |
| Minority Stockholder's Interest |
11,272,400.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,338,519,932.56 |
| Owner's Equity（Stockholder's Equity） |
1,349,792,332.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,579,010,212.03 |
